Organigram Global Inc. (OGI)
OGINASDAQ-GSBiotechnology: Pharmaceutical Preparations
$0.8560
-0.0200 (-2.28%) today
Regular session, Nov 10, 3:06 PM ET
- Market cap
- $120.74m
- P/E
- –
- EPS, last 4 quarters
- $-0.2800
- Dividend yield
- –
- Day range
- $0.8500 to $0.8800
- 52-week range
- $0.8531 to $2.24
- Average volume
- 523.0k
- Previous close
- $0.8760
Analysts
2 coveringBuy2 buy, 0 hold, 0 sell
Targets a year out average $2.21, +158.2% from here
Earnings
next estimate $0.0200Next report Dec 15, 2026
Sep 2025
-1900.0%
Dec 2025
-100.0%
Mar 2026
0.0%
Jun 2026
-400.0%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- The Big Winner From the Aurora Cannabis-Organigram Deal: CuraleafThe Motley Fool · 1 day ago
- Aurora Cannabis Stock: What Organigram's Buyout Means for InvestorsZacks · 6 days ago
- Organigram To Acquire Aurora Cannabis In C$561 Mln Deal RTTNews · Nov 3, 2026
- Organigram Global Targets Profitable Growth With Canada Focus and German ExpansionMarketBeat · Sep 30, 2026
- Organigram (OGI) Q3 2026 Earnings Call TranscriptThe Motley Fool · Aug 18, 2026
- Organigram Global Q3 Earnings Call HighlightsMarketBeat · Aug 11, 2026
- CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue EstimatesZacks · Aug 10, 2026
- Health Catalyst (HCAT) Beats Q2 Earnings and Revenue EstimatesZacks · Aug 6, 2026
The company
Organigram Global Inc. is listed on the NASDAQ Global Select Market and TSX. The Company's wholly owned subsidiary, Organigram Inc. , is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH (' Sanity Group '), Organigram participates in the German medical cannabis market and other emerging markets within Europe . Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, Monjour, Tremblant, Collective Project , Trailblazer, BOXHOT and DEBUNK. Through its acquisition of Sanity Group , Organigram's European brands include Vayamed, avaay, ZOIKS, Endosane Pharmaceuticals , VAAY, and Grashaus Projects. Organigram operates facilities in Moncton, New Brunswick and Lac Superieur, Quebec , with a dedicated edibles manufacturing facility in Winnipeg, Manitoba .
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- organigram.ca
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.